The features of developing rat autoimmune pathology with mitochondrial dysfunction
- Authors: Skupnevskiy S.V.1, Pukhaeva E.G.1, Badtiev A.K.1, Rurua F.K.1, Batagova F.E.1, Farnieva Z.G.1
-
Affiliations:
- Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
- Issue: Vol 13, No 1 (2023)
- Pages: 161-166
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/2220-7619/article/view/126045
- DOI: https://doi.org/10.15789/2220-7619-TFO-2038
- ID: 126045
Cite item
Full Text
Abstract
The central role of the mitochondria in energy supply and cell death determines highlight these organelles as one of the promising objects for investigating pathogenesis of immune-mediated inflammatory disorders. The aim: to study features of pathogenesis in rat adjuvant-induced autoimmune pathology separately and in combination with mitochondrial disorders. Materials and methods. Wistar rats were divided into groups of negative control (solvent), positive control (single subcutaneous injection of complete Freund’s adjuvant (CAF) at dose of 0.1 ml/200 g body weight), experimental (CAF 0.1 ml/200 g body weight and 5 weeks later — with cuprizone 0.2% per feed weight). At the end of experiment (7 weeks), animals were tested in the “open field” model, euthanized, and biomaterial was collected to measure the relative mass coefficients of internal organs, hematological and histological studies. We calculated the mean, standard error of the mean; comparison of hypotheses was carried out by paired Student’s t-test. Results. In case of impaired immunological tolerance there was detected reduced rat body weight gain during the study period (negative control +74.7 g, positive control +10.3 g) along with modelled mitochondrial dysfunction, a general decrease in weight by 6.7 g was noted. The magnitude of mass coefficients indicate a relative reduction in mass of liver, kidneys, spleen and thymus in experimental animals. The leukocyte counts (× 109/L) are as follows: negative control — 8.68±0.37, positive control — 10.98±1.03 (p < 0.05), experimental group — 12.28±0.63 (p < 0.001). No significant changes were found in the leukocyte formula and the red cell lineage. During modelled autoimmune pathology, platelet count increased by 22.5% (p < 0.05), whereas after cuprizone was administered it decreased by 6.3% (relative to the negative control). Mitochondrial dysfunction caused an abrupt decrease in motor activity in rats: the number of crossed sectors in positive control animals was 55.50±6.91, experimental group — 44.50±3.60 (inter-group comparison, p < 0.001). Positive control: enlarged lymphatic nodules were found in the spleen, germinal center clarification, wall thickening of the pulpal and central arteries; single foci of hemorrhages in the red pulp. Experimental group: atrophy of lymphoid follicles of varying severity (relative to the groups of negative and positive controls), numerous foci of hemorrhages with hemosiderosis in the red pulp. Conclusion. Mitochondrial dysfunction is accompanied by augmented pathogenetic signs of autoimmune pathology, which can serve as one of the keys to understanding the mechanisms of human autoimmunity.
Full Text
##article.viewOnOriginalSite##About the authors
Sergeii V. Skupnevskiy
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Email: medgenetika435@yandex.ru
DSc (Biology), Leading Researcher, Laboratory of Subcellular Structures, Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazElena G. Pukhaeva
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Author for correspondence.
Email: medgenetika435@yandex.ru
Junior Researcher, Laboratory of Subcellular Structures, Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazAlibek K. Badtiev
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Email: medgenetika435@yandex.ru
PhD (Biology), Senior Researcher, Laboratory of Subcellular Structures, Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazFatima K. Rurua
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Email: medgenetika435@yandex.ru
Junior Researcher, Laboratory of Subcellular Structures, Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazFatima E. Batagova
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Email: medgenetika435@yandex.ru
Junior Researcher, Laboratory of Subcellular Structures, Postgraduate of the Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazZhanna G. Farnieva
Institute of Biomedical Investigations — the Affiliate of Vladikavkaz Scientific Centre of RAS
Email: medgenetika435@yandex.ru
Junior Researcher, Laboratory of Subcellular Structures, Postgraduate of the Department of Molecular and Cellular Mechanisms of Autoimmune Diseases
Russian Federation, VladikavkazReferences
- Будихина А.С., Пащенков М.В. Роль гликолиза в иммунном ответе // Иммунология. 2021. Т. 42, № 1. С. 5–20. [Budikhina A.S., Pashchenkov M.V. The role of glycolysis in the immune response. Immunologiya = Immunologiya, 2021, vol. 42, no. 1. pp. 5–20. (In Russ.)] doi: 10.33029/0206-4952-2021-42-1-5-20
- Григорьев Е.В., Салахов Р.Р., Голубенко М.В., Понасенко А.В., Шукевич Д.Л., Матвеева В.Г., Радивилко А.С., Цепокина А.В., Великанова Е.А., Корнелюк Р.А., Ивкин А.А. Митохондриальная ДНК как кандидатный DAMP при критических состояниях // Бюллетень сибирской медицины. 2019. Т. 18, № 3. С. 134–143. [Grigor’ev E.V., Salakhov R.R., Golubenko M.V., Ponasenko A.V., Shukevich D.L., Matveeva V.G., Radivilko A.S., Tsepokina A.V., Velikanova E.A., Kornelyuk R.A., Ivkin A.A. Mitochondrial DNA as a candidate DAMP in critical conditions. Byulleten’ sibirskoi meditsiny = Bulletin of Siberian Medicine, 2019, vol. 18, no. 3, pp. 134–143. (In Russ.)] doi: 10.20538/1682-0363-2019-3-134-143
- Пинегин Б.В., Воробьева Н.В., Пащенков М.В., Черняк Б.В. Роль митохондриальных активных форм кислорода в активации врожденного иммунитета // Иммунология. 2018. Т. 39, № 4. С. 221–229. [Pinegin B.V., Vorob’eva N.V., Pashchenkov M.V., Chernyak B.V. The role of mitochondrial reactive oxygen species in the activation of innate immunity. Immunologiya = Immunologiya, 2018, vol. 39, no. 4. pp. 221–229. (In Russ.)] doi: 10.18821/0206-4952-2018-39-4-221-229
- Шейбак В.М., Павлюковец А.Ю. Биохимическая гетерогенность Т-лимфоцитов // Вестник ВГМУ. 2018. Т. 17, № 6. С. 7–17. [Sheibak V.M., Pavlyukovets A.Yu. Biochemical heterogeneity of T-lymphocytes. Vestnik Vitebskogo Gosudarstvennogo Meditsinskogo Universiteta = Vitebsk Medical Jornal, 2018, vol. 17, no. 6. pp. 7–17. (In Russ.)] doi: 10.22263/2312-4156.2018.5.7
- Abdel El-Gaphar O.A.M., Abo-Youssef A.M., Abo-Saif A.A. Effect of losartan in complete freund’s adjuvant-induced arthritis in rats. Iran J. Pharm. Res., 2018, vol. 17, no. 4, pp. 1420–1430.
- Rashida Gnanaprakasam J.N., Wu R., Wang R. Metabolic reprogramming in modulating t cell reactive oxygen species generation and antioxidant capacity. Front. Immunol., 2018, vol. 16, no. 9: 1075. doi: 10.3389/fimmu.2018.01075
- Shekhova E. Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity. PLoS Pathog., 2020, vol. 16, no. 5: 1008470. doi: 10.1371/journal.ppat.1008470
- Tavassolifar M.J., Vodjgani M., Salehi Z., Izad M. The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis. Autoimmune Dis., 2020, vol. 2020: 5793817. doi: 10.1155/2020/5793817
- Varhaug K.N., Kråkenes T., Alme M.N., Vedeler C.A., Bindoff L.A. Mitochondrial complex IV is lost in neurons in the cuprizone mouse model. Mitochondrion, 2020, vol. 50, pp. 58–62. doi: 10.1016/j.mito.2019.09.003
- Zischka H., Einer C. Mitochondrial copper homeostasis and its derailment in Wilson disease. Int. J. Biochem. Cell. Biol., 2018, vol. 102, pp. 71–75. doi: 10.1016/j.biocel.2018.07.001
Supplementary files
